Delivery Order SPE2DR25D2103-SPE2DR26F91UY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Yonsa 125 mg tablets in quantities of 120 units. This competitively awarded, non-set-aside contract carries a ceiling value of $19,149.36 and is structured as a firm fixed price delivery order, with an ultimate completion date of January 9, 2026. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a $2,393.67 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on November 5, 2025, with completion targeted for November 28, 2025. This competitive, non-set-aside contract represents a firm fixed-price delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Yonsa 125 mg tablets (120 count) with a ceiling value of $2,393.67. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by January 15, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,542.74 to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg, a pharmaceutical product. The contract, awarded on August 12, 2025, carries a firm fixed-price structure with an ultimate completion date of September 3, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Yonsa 125 mg tablets (120-count units). This non-set-aside, competitively awarded contract carries a ceiling value of $14,362.02 and was executed on December 16, 2025, with an ultimate completion date of January 8, 2026. The contract employs firm fixed price terms and is classified as a delivery order, indicating...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 11, 2025, for the supply of Yonsa 125 mg tablets (120-count units) with a ceiling value of $4,787.34. This is a firm fixed-price delivery order with an ultimate completion date of January 5, 2026. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $9,085.44 to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg, a pharmaceutical product supporting military healthcare needs. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,271.36 for 120 tablets of YONSA 125 mg on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, competitively awarded contract required no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Yonsa (125 mg tablets, 120-count package) under a firm fixed-price contract with a ceiling value of $2,393.67 and an ultimate completion date of January 13, 2026. This competitive, non-set-aside award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,814.08 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units) on September 24, 2025, with completion targeted for October 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- SPE2DR25D2103Indefinite Delivery Contract
- SPE2DR25D2103-SPE2DR26F91UYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supply on December 23, 2025, with a ceiling value of $7,181.01 and an ultimate completion date of January 15, 2026. The contract covers the delivery of Yonsa 125 mg tablets in quantities of 120 units, utilizing firm fixed price pricing. This competitively awarded, non-set-aside delivery order is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and other therapeutic products across multiple domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 12/22/25 |